Concepedia

Ajinkya Patil

AP

13

Publications

1.2K

Citations

12

H-Index

2008

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Broad Institute

Howard Hughes Medical Institute

Northwestern University

Ajinkya Patil is an author at Dana-Farber Cancer Institute specializing in medicine, cancer research, and t cell immunity.

ORCID

Top concepts

Publications per year

2008–2023

13

Publications

13

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Jin Wei, Mia Madel Alfajaro, Peter C. DeWeirdt et al. · Cell · 2020 · 572 citations · Full text

, , +8

The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation

Timothy D. Martin, Rupesh S. Patel, Danielle Cook et al. · Science · 2021 · 155 citations

, , +21

A disordered region controls cBAF activity via condensation and partner recruitment

Ajinkya Patil, Amy R. Strom, João A. Paulo et al. · Cell · 2023 · 138 citations · Full text

Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma

Mark Manzano, Ajinkya Patil, Alexander Waldrop et al. · Nature Communications · 2018 · 63 citations · Full text

CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma

Ajinkya Patil, Mark Manzano, Eva Gottwein · Blood · 2018 · 43 citations · Full text

Rows per page

1–5 of 13